Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients
about
Redox mechanisms in age-related lung fibrosisMolecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersMechanisms of alveolar epithelial injury, repair, and fibrosisHeterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisC-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings.Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?Fibrosis: ultimate and proximate causesAutoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary FibrosisSerum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung diseaseImmune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis.Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12Molecular biomarkers in interstitial lung diseases.The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary FibrosisDeep Proteome Profiling Reveals Common Prevalence of MZB1-positive Plasma B Cells in Human Lung and Skin Fibrosis.Idiopathic pulmonary fibrosis and a role for autoimmunity.B lymphocytes in renal interstitial fibrosis.New treatment directions for IPF: current status of ongoing and upcoming clinical trials.The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.Targeting B lymphocytes in progressive fibrosing mediastinitis.Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.Investigational drugs for idiopathic pulmonary fibrosis.Association between nonspecific interstitial pneumonia and presence of CD20+ B lymphocytes within pulmonary lymphoid follicles.Adaptive Immunity and Metabolic Health: Harmony Becomes Dissonant in Obesity and Aging.Mitochondrial Dysfunction in Pulmonary Fibrosis.The Immunome in Two Inherited Forms of Pulmonary Fibrosis.Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis.
P2860
Q26743421-CF90A09E-A655-43C0-9ABB-B1C3808A4DA2Q26864836-4BB0018B-5F20-4299-A957-EA4F41C83822Q27023971-27171DDF-F56B-4E5D-B67E-373E7C0CB719Q27316615-D29BC95F-7547-419A-83A1-7C24352FCD6FQ33901646-BF216500-9D18-48F3-85C6-6BD42114EAEDQ34019921-26A647F1-E603-410D-A339-6ACD44F152F9Q35121494-896F32D0-826B-45B9-9B2F-8D2482DB6108Q35140034-C6930A73-DCFD-4AE9-9F80-B23CD21CE279Q35666076-6C65CAB9-ECF4-4953-9F57-430D17640ACCQ35794515-DB85078C-176B-4372-8767-1FEE0E47741CQ36012118-348E43F9-43EC-4B99-88F8-FA52B83D30FBQ36385061-2F38F933-3E64-41E9-87B2-6C0575ECC079Q37681533-6DEB4DAD-09A8-4DC3-ABB2-7069FCABBCAAQ38220769-F3DD2737-DA83-40AA-8F81-816828D49DE3Q38290539-50DC723B-1D4E-494C-84FE-A345B03A971AQ38654419-F3382E78-BA7E-46C7-80C2-1A6972EE8561Q38666089-B5FCF9DF-3EA2-4139-A954-227D3FE0F4EFQ38737879-8DBC0164-B83C-4E1F-8AEB-7A482DC6F694Q38756261-47602E1B-D227-408D-88EA-37223BD98BB7Q39330304-22617F2B-B710-44F8-9236-100437C4747AQ42694416-6F5A5544-254C-43C9-AB28-E1FE96DD3E83Q42763843-CD7AB2E0-4F94-4611-B88C-92DBF2C8EEFFQ46125322-2D4069EB-720B-411B-9C0D-C3B18ACE8461Q46325791-21066FFC-50F7-4797-8DB4-81F9C1A5DA27Q47113769-AABB4434-2F05-483C-A861-5480EA2A096EQ47670316-EA6F81C0-60AB-448B-8521-89E0169E0606Q48261825-0A6C2AB4-3F9A-4CC2-B468-4891677FFED2Q49323930-7B7CF160-95EE-4788-AD23-20E5B439D517Q55009120-163D4D9E-1AFF-44F7-A105-A615DC8ED480
P2860
Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma B lymphocyte stimulator ...... ic pulmonary fibrosis patients
@en
Plasma B lymphocyte stimulator ...... c pulmonary fibrosis patients.
@nl
type
label
Plasma B lymphocyte stimulator ...... ic pulmonary fibrosis patients
@en
Plasma B lymphocyte stimulator ...... c pulmonary fibrosis patients.
@nl
prefLabel
Plasma B lymphocyte stimulator ...... ic pulmonary fibrosis patients
@en
Plasma B lymphocyte stimulator ...... c pulmonary fibrosis patients.
@nl
P2093
P2860
P50
P921
P356
P1476
Plasma B lymphocyte stimulator ...... ic pulmonary fibrosis patients
@en
P2093
Daniel J Kass
Jessica Bon
Jiangning Tan
Jianmin Xue
Joseph M Pilewski
Kevin F Gibson
Louis Vuga
Makoto Soejima
Marc C Levesque
Michael Donahoe
P2860
P304
P356
10.4049/JIMMUNOL.1203476
P407
P577
2013-07-19T00:00:00Z